BMT CTN Protocol 0201

A Phase III Randomized Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell with Marrow Transplantation from HLA Compatible Unrelated Donors

Below are protocol-related doucments, which may be periodically updated.

The BMT CTN #0201 study met its target accrual of 550 patients and closed enrollment on September 9, 2009.